02138 EC HEALTHCARE
- 1.900
- +0.370+24.18%
EC HEALTHCARE News
Hong Kong Stock Afternoon Review | Tech Index rose nearly 1%, TechNet stocks and biotech stocks rose higher, Bilibili rose more than 6%, and Laikai Pharmaceuticals rose more than 12%
Auto stocks rose more than 6%; Great Wall Motor rose more than 6%; NIO and Zero Sports Auto rose more than 5%; many coal stocks fell sharply, Yankuang Energy fell more than 6%, and Shougang resources fell nearly 6%.
Changes in Hong Kong stocks | MedicalHealth (02138) surged more than 35%, and overall annual sales are expected to exceed HK$4.2 billion, up more than 8% year on year
Medical Thinking Health (02138) surged by more than 35% in the intraday period. As of press release, it rose 22.22% to HK$1.87, with a turnover of HK$29.7763 million.
Hong Kong Bourse Allows EC Healthcare to Delay Circular Dispatch for Proposed Acquisition
EC Healthcare (HKG:2138) has received a waiver from the Hong Kong Stock Exchange to delay the dispatch of a circular regarding the purchase of further interest in Pangenia to on or before June 15, a M
Featured announcements | Great Wall Motor's sales increased by nearly 20% in the first 4 months; Jindi Commercial's sales fell by more than 50% during the year
Great Wall Motor's sales increased by nearly 20% in the first 4 months. What are the highlights of export performance?
EC Healthcare Sales Volume Unchanged for Q2 of Fiscal 2024
The overall sales volume of EC Healthcare (HKG:2138) remained unchanged during the second half of the fiscal year ending March 31, a Monday filing on the Hong Kong bourse stated. For the full year end
Medical Thinking Health (02138) expects overall annual sales of not less than HK$4.2 billion to increase by no less than 8% year over year
Medical Thinking Health (02138) issued an announcement. The Group expects to achieve overall sales for the year ending March 31, 2024...
The market is picking up, and listed companies are pouring in medical and aesthetic institutions. Who will win the next “C-rank material”?
Catalyzed by various factors, the medical and aesthetic market recovered to a certain extent in the first quarter, while the performance of listed companies, whether midstream medical and aesthetic institutions or upstream producers, has steadily improved since this year.
Express News | General Administration of Market Regulation: Maintain a high-pressure crackdown on illegal acts of medical and aesthetic advertising and strictly regulate the publication of medical and aesthetic advertisements
MedicalHealth (02138.HK) appoints EY as new auditor
Gelonghui, March 19 | Medical Healthcare (02138.HK) announced that due to the failure of the company and KPMG to agree on audit fees for the financial year ending March 31, 2024, KPMG has resigned as the company's auditor, effective March 19, 2024. Based on the recommendation of the Audit Committee, the Board of Directors resolved to appoint Ernst & Young as the company's new auditor with effect from March 19, 2024 to fill the temporary vacancy after KPMG's resignation. EY's term of office will last until the end of the company's next Annual General Meeting of Shareholders.
Changes in Hong Kong stocks | MedicalHealth (02138) surged more than 15%. Overall sales for the quarter ending 2023 are expected to be no less than HK$1.1 billion, up no less than 7% year over year
Medical Thinking Health (02138) surged more than 15%. As of press release, it rose 15.69% to HK$1.77, with a turnover of HK$5.35 million.
Express News | Fangzheng Securities: The cosmetics, medical and aesthetic industries are expected to usher in strong breakthroughs
The Little Peak of Medicine and Aesthetics is here! There was a wave of beauty concentrated before the Spring Festival, but why did the practitioners continue to complain? |Industry Watch
Ultrasound cannons are booked three days in advance, and the administration is transferred to the front desk to receive customers... A Financial Association reporter recently visited several medical and aesthetic institutions in Chengdu and found that as the Spring Festival approaches, there has been a marked increase in the number of consumers visiting hospitals for consultation and treatment, and some popular programs require advance reservations.
Changes in Hong Kong stocks | MedicalHealth (02138) rose more than 26% and sales are expected to increase by no less than 7% year-on-year in the third quarter of FY24
Medical Thinking Health (02138) rose by more than 26%. As of press release, it rose 21.24% to HK$1.37, with a turnover of HK$8.6623 million.
EC Healthcare's Overall Sales Volume Rises 7% in Q4 2023
The overall sales of non-hospital medical service provider EC Healthcare (HKG:2138) rose 7% in the fourth quarter of 2023. Included in the sales volume are medical services, and aesthetic medical and
Featured announcements | Great Wall Motor's revenue last year increased 26% year on year; COSCO Haineng's net profit pre-increased by about 112% to 167% last year
CITIC Securities Performance Report: Net profit of 19.686 billion yuan was achieved in 2023, down 7.65% from the previous year; Qiu Titanium Technology's earnings warning: Annual shareholders' comprehensive profit is expected to decrease by about 35% to 45%.
Medical Thinking Health (02138.HK)'s overall sales volume for the three months ended 31 December exceeded HK$1.1 billion, up more than 7% year on year
Gelonghui, January 23 | Medical Health (02138.HK) announced that for the three months ending December 31, 2023, the Group is expected to record: (i) overall sales of no less than HK$1.1 billion during the quarter, an increase of no less than 7% over the same period last year; (ii) sales of medical services provided by the Group during the quarter increased by no less than 6% over the same period last year; (iii) the sales volume of the Group's aesthetic medicine, beauty and wellness services in Hong Kong and Macau during the quarter increased by no less than 5% compared to the same period last year; (iv) the sales volume of the Group's aesthetic medicine, beauty and wellness services in mainland China during the quarter compared to the same period last year; (iv) the sales volume of the Group's aesthetic medicine, beauty and wellness services in mainland China during the quarter compared to the same period last year; (iv) the sales volume of the Group's aesthetic medicine, beauty and wellness services in main
EC Healthcare Further Acquires Stake in Pangenia for HK$33.2 Million
EC Healthcare (HKG:2138) further acquired 12.4% of British Virgin Islands-incorporated Pangenia for a consideration of HK$33.2 million. The company already bought 42.9% of Pangenia through the acquisi
MedicalHealth (02138) plans to spend HK$33.2 million to further acquire 12.38% of Xinya's shares
MedicalHealth (02138) announced that it has acquired Active Compass Limit...
Medical and aesthetic recovery stalled in the second half of the year, triggering a price war. Listed companies target a new “optoelectronic anti-aging” track|year-end inventory
Financial Services Association, December 26 (Reporter He Fan) As the end of the year progresses, the medical and aesthetic market does not seem to be “in full swing” as predicted at the beginning of the year.
醫思健康：2023/24半年度業績報告
Analysis
Price Target
No Data
